BRPI0924899B8 - Síntese hmo - Google Patents

Síntese hmo

Info

Publication number
BRPI0924899B8
BRPI0924899B8 BRPI0924899A BRPI0924899A BRPI0924899B8 BR PI0924899 B8 BRPI0924899 B8 BR PI0924899B8 BR PI0924899 A BRPI0924899 A BR PI0924899A BR PI0924899 A BRPI0924899 A BR PI0924899A BR PI0924899 B8 BRPI0924899 B8 BR PI0924899B8
Authority
BR
Brazil
Prior art keywords
cell
synthesis
transformed
nucleic acid
acid sequence
Prior art date
Application number
BRPI0924899A
Other languages
English (en)
Inventor
Jennewein Stefan
Hüfner Eric
Parkot Julia
Original Assignee
Jennewein Biotechnologie Gmbh
Chr Hansen Hmo Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40941939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0924899(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jennewein Biotechnologie Gmbh, Chr Hansen Hmo Gmbh filed Critical Jennewein Biotechnologie Gmbh
Publication of BRPI0924899A2 publication Critical patent/BRPI0924899A2/pt
Publication of BRPI0924899B1 publication Critical patent/BRPI0924899B1/pt
Publication of BRPI0924899B8 publication Critical patent/BRPI0924899B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SÍNTESE HMO. A presente invenção se refere a uma célula estavelmente cultivada em um meio, cuja célula é ajustada para a produção de oligossacarídeos, a célula sendo transformada para compreender pelo menos uma sequência de ácido nucléico que codifica uma enzima envolvida na síntese de oligossacarídeo. Além disto, a célula é transformada para compreender pelo menos uma sequência de ácido nucléico que codifica uma proteína da família de transportador de efluxo de açúcar, um homólogo funcional ou um derivado deste. Adicionalmente, a invenção inclui um método para a produção de oligossacarídeos que envolvem a célula acima descrita.
BRPI0924899A 2009-06-08 2009-06-08 Síntese hmo BRPI0924899B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/004112 WO2010142305A1 (en) 2009-06-08 2009-06-08 Hmo synthesis

Publications (3)

Publication Number Publication Date
BRPI0924899A2 BRPI0924899A2 (pt) 2021-02-23
BRPI0924899B1 BRPI0924899B1 (pt) 2022-03-22
BRPI0924899B8 true BRPI0924899B8 (pt) 2023-01-31

Family

ID=40941939

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0924899A BRPI0924899B8 (pt) 2009-06-08 2009-06-08 Síntese hmo

Country Status (15)

Country Link
US (2) US8652808B2 (pt)
EP (1) EP2440661B1 (pt)
JP (1) JP5580408B2 (pt)
CN (2) CN106978382A (pt)
AU (1) AU2009347610B2 (pt)
BR (1) BRPI0924899B8 (pt)
DK (1) DK2440661T3 (pt)
ES (1) ES2660698T3 (pt)
MX (1) MX2011013231A (pt)
MY (1) MY182355A (pt)
NZ (1) NZ597129A (pt)
PL (1) PL2440661T3 (pt)
RU (1) RU2517602C2 (pt)
SG (1) SG176651A1 (pt)
WO (1) WO2010142305A1 (pt)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY182355A (en) * 2009-06-08 2021-01-20 Chr Hansen Hmo Gmbh Hmo synthesis
BR112012030836B8 (pt) 2010-06-02 2024-02-06 Evolva Nutrition Inc Hospedeiro recombinante que compreende genes recombinantes para produção de esteviol ou glicosídeo de esteviol, método para produzir esteviol, glicosídeo de esteviol ou composição de glicosídeo de esteviol e método para sintetizar esteviol ou glicosídeo de esteviol
EP2455387A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
WO2013022989A2 (en) 2011-08-08 2013-02-14 Evolva Sa Recombinant production of steviol glycosides
CN102839157A (zh) * 2012-07-12 2012-12-26 扬州大学 稳定共表达hST3GalIV和β1-4GalT1的MDCK细胞系及构建方法和应用
WO2014086373A1 (en) 2012-12-07 2014-06-12 Glycom A/S Crystallisation of human milk oligosaccharides (hmo)
MY190346A (en) 2013-02-06 2022-04-15 Evolva Sa Methods for improved production of rebaudioside d and rebaudioside m
BR112015019160A2 (pt) 2013-02-11 2017-08-22 Dalgaard Mikkelsen Michael Produção de glicosídeos de esteviol em hospedeiros recombinantes
WO2014135167A1 (en) * 2013-03-08 2014-09-12 Glycom A/S Purification of oligosaccaharides by reversible derivatization
WO2015032412A1 (en) 2013-09-06 2015-03-12 Glycom A/S Fermentative production of oligosaccharides
DK2845905T3 (da) 2013-09-10 2021-06-14 Chr Hansen Hmo Gmbh Fremstilling af oligosaccharider
EP2857410A1 (en) * 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
EP2896628B1 (en) * 2014-01-20 2018-09-19 Jennewein Biotechnologie GmbH Process for efficient purification of neutral human milk oligosaccharides (HMOs) from microbial fermentation
EP2905341B1 (en) * 2014-02-07 2020-04-29 Jennewein Biotechnologie GmbH Methods for producing GDP-fucose using nucleotide sugar transporters and recombinant microorganism host cells used therefor
DK2927316T3 (en) 2014-03-31 2019-03-04 Jennewein Biotechnologie Gmbh Total fermentation of oligosaccharides
SG10201901007PA (en) 2014-08-11 2019-03-28 Evolva Sa Production of steviol glycosides in recombinant hosts
WO2016038095A2 (en) 2014-09-09 2016-03-17 Evolva Sa Production of steviol glycosides in recombinant hosts
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
CN107427042A (zh) * 2015-01-26 2017-12-01 卡德纳生物股份有限公司 用作食品成分的寡糖组合物和其制造方法
CN108337892B (zh) 2015-01-30 2022-06-24 埃沃尔瓦公司 在重组宿主中生产甜菊醇糖苷
EP3862426A3 (en) 2015-03-16 2021-11-17 DSM IP Assets B.V. Udp-glycosyltransferases
US10837041B2 (en) 2015-08-07 2020-11-17 Evolva Sa Production of steviol glycosides in recombinant hosts
EP3141610A1 (en) * 2015-09-12 2017-03-15 Jennewein Biotechnologie GmbH Production of human milk oligosaccharides in microbial hosts with engineered import / export
CN109195457A (zh) 2016-04-13 2019-01-11 埃沃尔瓦公司 在重组宿主中产生甜菊醇糖苷
US10815514B2 (en) 2016-05-16 2020-10-27 Evolva Sa Production of steviol glycosides in recombinant hosts
CN106190937B9 (zh) * 2016-07-18 2020-12-01 南开大学 一种构建重组大肠杆菌生物合成2’-岩藻乳糖的方法
ES2856749T3 (es) 2016-10-29 2021-09-28 Chr Hansen Hmo Gmbh Proceso para la producción de oligosacáridos fucosilados
CN110100006A (zh) 2016-11-07 2019-08-06 埃沃尔瓦公司 重组宿主中甜菊糖苷的生产
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN110832073A (zh) * 2017-03-31 2020-02-21 株式会社钟化 新型单加氧酶及其用途
WO2019003135A1 (en) 2017-06-30 2019-01-03 Glycom A/S PURIFICATION OF OLIGOSACCHARIDES
EP3425052A1 (en) 2017-07-07 2019-01-09 Jennewein Biotechnologie GmbH Fucosyltransferases and their use in producing fucosylated oligosaccharides
CN110914284A (zh) 2017-07-12 2020-03-24 格礼卡姆股份公司 包含中性单糖或寡糖和酸性非碳水化合物组分的无定形混合物
EP3438122A1 (en) 2017-08-01 2019-02-06 OligoScience Biotechnology GmbH Microorganism for producing human milk oligosaccharide
CN107805622B (zh) * 2017-11-08 2021-04-30 光明乳业股份有限公司 一种合成鸟苷二磷酸岩藻糖的重组枯草芽孢杆菌及其构建方法与应用
EP3486326A1 (en) 2017-11-21 2019-05-22 Jennewein Biotechnologie GmbH Method for the purification of n-acetylneuraminic acid from a fermentation broth
US11913046B2 (en) 2018-04-23 2024-02-27 Inbiose N.V. Increasing export of 2'fucosyllactose from microbial cells through the expression of a heterologous nucleic acid
EP3784772A1 (en) * 2018-04-23 2021-03-03 DuPont Nutrition Biosciences ApS Increasing activity of 2' fucosyllactose transporters endogenous to microbial cells
CN109735479B (zh) * 2019-01-30 2022-04-01 光明乳业股份有限公司 一种合成2’-岩藻糖基乳糖的重组枯草芽孢杆菌及其构建方法与应用
EP3702468A1 (en) * 2019-03-01 2020-09-02 Jennewein Biotechnologie GmbH Fermentative production of carbohydrates by microbial cells utilizing a mixed feedstock
KR102254548B1 (ko) * 2019-04-26 2021-05-24 고려대학교 산학협력단 돌연변이 대장균을 이용한 콜라닉 산 생산
EP3751003A1 (en) 2019-06-12 2020-12-16 Jennewein Biotechnologie GmbH Production of fucosylated oligosaccharides in bacillus
CN114466934A (zh) * 2019-07-19 2022-05-10 因比奥斯公司 在宿主细胞中生产岩藻糖基乳糖
US20220298536A1 (en) * 2019-08-13 2022-09-22 Amyris, Inc. Improved oligosaccharide production in yeast
CN110396532A (zh) * 2019-08-23 2019-11-01 中国科学院合肥物质科学研究院 一种制备唾液酸乳糖的方法
EP4045518A1 (en) * 2019-10-14 2022-08-24 Inbiose N.V. Production of bioproduct in a host cell
CN114901825A (zh) * 2019-12-18 2022-08-12 因比奥斯公司 在宿主细胞中产生唾液酸化寡糖
JP2023511522A (ja) 2020-01-23 2023-03-20 グリコム・アクティーゼルスカブ Ｈｍｏの産生
JP2023511524A (ja) * 2020-01-23 2023-03-20 グリコム・アクティーゼルスカブ Ｈｍｏ産生
US20230072639A1 (en) 2020-01-23 2023-03-09 Glycom A/S New major facilitator superfamily (mfs) protein (bad) in hmo production
US20230193335A1 (en) 2020-01-23 2023-06-22 Glycom A/S Hmo production
EP3929300A1 (en) 2020-06-26 2021-12-29 Chr. Hansen HMO GmbH Improved export of oligosaccharides from bacterial cells
DK180952B1 (en) 2020-12-22 2022-08-10 Glycom As A dfl-producing strain
EP4281564A1 (en) 2021-01-22 2023-11-29 Glycom A/S New major facilitator superfamily (mfs) protein (fred) in production of sialylated hmos
JPWO2022168991A1 (pt) 2021-02-08 2022-08-11
DK181497B1 (en) 2021-05-17 2024-03-12 Dsm Ip Assets Bv ENHANCING FORMATION OF THE HMOS LNT AND/OR LNnT BY MODIFYING LACTOSE IMPORT IN THE CELL
WO2022243311A1 (en) 2021-05-17 2022-11-24 Dsm Ip Assets B.V. Microbial strain expressing an invertase/sucrose hydrolase
DK181242B1 (en) 2021-05-17 2023-05-30 Dsm Ip Assets Bv GENETICALLY ENGINEERED CELLS COMPRISING A RECOMBINANT NUCLEIC ACID SEQUNCE ENCODING AN α-1,2-FUCOSYLTRANSFERASE CAPABLE OF PRODUCING LNFP-I, NUCLEIC ACID SEQUENCES ENCODING SAME AND METHODS FOR USE OF SAME
CN115029371B (zh) * 2022-06-14 2024-01-02 大连工业大学 一种微生物生产的天然活性产物的高效分离方法
DK202200689A1 (en) 2022-07-15 2024-02-27 Dsm Ip Assets Bv New fucosyltransferases for in vivo synthesis of lnfp-iii
WO2024042235A1 (en) 2022-08-25 2024-02-29 Dsm Ip Assets B.V. Hybrid method for producing complex hmos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204431B1 (en) * 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
US20080145899A1 (en) 2004-09-17 2008-06-19 Neose Technologies Inc Production of Oligosaccharides By Microorganisms
EP2379708B1 (en) 2008-12-19 2016-04-27 Jennewein Biotechnologie GmbH Synthesis of fucosylated compounds
MY182355A (en) * 2009-06-08 2021-01-20 Chr Hansen Hmo Gmbh Hmo synthesis

Also Published As

Publication number Publication date
MY182355A (en) 2021-01-20
US9512433B2 (en) 2016-12-06
JP2012529274A (ja) 2012-11-22
DK2440661T3 (en) 2018-03-12
NZ597129A (en) 2012-12-21
JP5580408B2 (ja) 2014-08-27
SG176651A1 (en) 2012-01-30
PL2440661T3 (pl) 2018-06-29
MX2011013231A (es) 2012-01-20
US8652808B2 (en) 2014-02-18
BRPI0924899A2 (pt) 2021-02-23
EP2440661A1 (en) 2012-04-18
BRPI0924899B1 (pt) 2022-03-22
CN106978382A (zh) 2017-07-25
CN102459605A (zh) 2012-05-16
EP2440661B1 (en) 2017-12-06
RU2011153792A (ru) 2013-07-20
RU2517602C2 (ru) 2014-05-27
US20140120611A1 (en) 2014-05-01
US20120135467A1 (en) 2012-05-31
ES2660698T3 (es) 2018-03-23
WO2010142305A1 (en) 2010-12-16
AU2009347610B2 (en) 2013-02-21
AU2009347610A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
BRPI0924899B8 (pt) Síntese hmo
BR112018004725A2 (pt) método para a produção de oligossacarídeos de leite humano em hospedeiros microbianos com importação/exportação modificada e célula hospedeira microbiana
BR112018000497A2 (pt) processo para preparação de um composto
BR112012016318A2 (pt) "alfa-amilase isolada, composição, método pra produzir amido liquefeito, processo para sintetizar um produto de fermentação, sequência de acidos nucleicos, célula hospedeira, e, método para preparar uma alfa-amilase."
BR112012014971A2 (pt) método para a produção de furfural a partir de material de biomassa lignocelulósica
BR112012007821A2 (pt) polipeptídeos para ligação ao "receptor de produtos finais de glicação avançada" bem como composições e métodos envolvendo os mesmos
EA201300074A1 (ru) Способ получения представляющего интерес соединения
BR112014009066B8 (pt) molécula de ácido nucleico, método para a sintetização de uma molécula de dna de triciclo-fosforotioato e composição farmacêutica
BR112018011801A2 (pt) ?método de produção de composições, composição e produto ingerível?
BR112012030197A2 (pt) diminuição do nível de lactato e aumento da produção de poliptídeo por subregulação da expressão de lactato desidrogenase e piruvato desidrogenase cinase.
CL2011002360A1 (es) Anticuerpo anti-alfa5beta1; molecula de acido nucleico que codifica el anticuerpo;celula huesped; metodo para produccionde anticuerpos anti-alfa5beta1; inmunoconjugado que comprende el anticuerpo; composicion farmaceutica.
BR112014020636A2 (pt) processo biotecnológico para produção de butanol e ácido butírico
BR112022000394A2 (pt) Produção de fucosilactose em células hospedeiras
BR112018076243A2 (pt) método para produção de derivado de difenil metano
BR112022011904A2 (pt) Produção de oligossacarídeo sialilado em células hospedeiras
BR112014004417B8 (pt) Processos de isomerização da glicose em frutose e de preparação de hmf a partir da glicose
BR122019022631B8 (pt) forma d de di-hidrato de cloreto de metiltionínio, seu processo de preparação, e composição farmacêutica
BR112014017804A8 (pt) Método para a produção do p-xileno e/ou do p-toluakdeído
BR112015032515A8 (pt) método para a produção de um açúcar líquido, método para a produção de um açúcar sólido, açúcar líquido, açúcar sólido e métodos para a produção de uma substância química
WO2012142147A3 (en) Synthesis and use of glycoside derivatives of propofol
BR112016023823A2 (pt) método para produção de um produto de fermentação
BR112012008378A2 (pt) Processo e dispositivo para a concentração de soluções de materiais.
BR112019000132A2 (pt) método para a produção fermentativa de moléculas de interesse por microrganismos compreendendo genes que codificam sistema de fosfotransferase de açúcar
BR112019010294A2 (pt) método para a produção enzimática de um anticorpo, anticorpo e formulação farmacêutica
BRPI1014066A8 (pt) Método para a fabricação de pirazóis substituídos por por piridil

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/06/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B25D Requested change of name of applicant approved

Owner name: CHR. HANSEN HMO GMBH (DE)